Minireview: Neuropeptide processing and its impact on melanocortin pathways

Endocrinology

Volumn 148, Issue 9, 2007, Pages 4201-4207

  Pritchard, Lynn E ^a   White, Anne ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Endocrine Sciences Research Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HYPOTHALAMUS HORMONE; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; NEUROPEPTIDE; CORTICOTROPIN; PROOPIOMELANOCORTIN;

BODY WEIGHT; CELL HETEROGENEITY; ENZYME REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; SECRETORY GRANULE; SHORT SURVEY; STATISTICAL SIGNIFICANCE; TRANS GOLGI NETWORK; ANIMAL; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENETICS; METABOLISM; PHYSIOLOGY; REVIEW; SECRETION;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BODY WEIGHT; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MELANOCORTINS; NEUROPEPTIDES; OBESITY; PRO-OPIOMELANOCORTIN; PROTEIN PROCESSING, POST-TRANSLATIONAL; SKIN PHYSIOLOGY;

EID: 34548061243     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1686     Document Type: Short Survey

References (81)

1. Bergeron F, Leduc R, Day R 2000 Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications. J Mol Endocrinol 24:1-22
2. Sanchez VC, Goldstein J, Stuart RC, Hovanesian V, Huo L, Munzberg H, Friedman TC, Bjorbaek C, Nillni EA 2004 Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin- releasing hormone. J Clin Invest 114:357-369
3. Eberle AN 2000 Proopiomelanocortin and the melanocortin peptides. In: Cone RD, ed. The melanocortin receptors. Totowa, NJ: Humana Press Inc.; 3-67
4. Pan H, Nanno D, Che FY, Zhu X, Salton SR, Steiner DF, Fricker LD, Devi LA 2005 Neuropeptide processing profile in mice lacking prohormone convertase-1. Biochemistry 44:4939-4948
5. Pan H, Che FY, Peng B, Steiner DF, Pintar JE, Fricker LD 2006 The role of prohormone convertase-2 in hypothalamic neuropeptide processing: a quantitative neuropeptidomic study. J Neurochem 98:1763-1777
6. Fricker LD, McKinzie AA, Sun J, Curran E, Qian Y, Yan L, Patterson SD, Courchesne PL, Richards B, Levin N, Mzhavia N, Devi LA, Douglass J 2000 Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci 20:639-648
7. Lindberg I, van den Hurk WH, Bui C, Batie CJ 1995 Enzymatic characterization of immunopurified prohormone convertase 2: potent inhibition by a 7B2 peptide fragment. Biochemistry 34:5486-5493
8. Pritchard LE, Turnbull AV, White A 2002 Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol 172:411-421
9. Wakamatsu K, Graham A, Cook D, Thody AJ 1997 Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res 10:288-297
10. Clark AJL 2000 The melanocortin-2 receptor in normal adrenocortical function and familial adrenocorticotropic hormone resistance. In: Cone RD, ed. The melanocortin receptors. Totowa, NJ: Humana Press Inc.; 361-384
11. Lu D, Haskell-Luevano C, Vage DI, Cone RD 2000 The melanocortin-1 receptor. In: Cone RD, ed. The melanocortin receptors. Totowa, NJ: Humana Press Inc.; 309-340
12. Chen W 2000 The melanocortin-5 receptor. In: Cone RD, ed. The melanocortin receptors. Totowa, NJ: Humana Press Inc.; 449-474
13. Kesterson RA 2000 The melancotin-3 receptor. In: Cone RD, ed. The melanocortin receptors. Totowa, NJ: Humana Press Inc.; 405-448
14. Cone RD 2005 Anatomy and regulation of the central melanocortin system. Nat Neurosci 8:571-578
15. Challis BG, Coll AP, Yeo GSH, Pinnock SB, Dickson SL, Thresher RR, Dixon J, Zahn D, Rochford JJ, White A, Oliver RL, Millington G, Aparicio SA, Colledge WH, Russ AP, Carlton MB, O'Rahilly S 2004 Mice lacking proopiomelanocortin are sensitive to high fat feeding but respond normally to the acute anorectic effects of peptide YY3-36. Proc Natl Acad Sci USA 101:4695-4700
16. Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, Mullis PE, Gruters A 2003 Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 88:4633-4640
17. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
18. Yeo GSH, Farooqi IS, Challis BG, Jackson RS, O'Rahilly S 2000 The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models. Q J M 93:7-14
19. Bjorbaek C, Kahn BB 2004 Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305-331
20. Adan RAH, Tiesjema B, Hillebrand JJG, la Fleur SE, Kas MJH, de Krom M 2006 The MC4 receptor and control of appetite. Br J Pharmacol 149:815-827
21. Li G, Mobbs CV, Scarpace PJ 2003 Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity and improved insulin sensitivity in genetically obese Zucker rats. Diabetes 52:1951-1957
22. Mizuno TM, Kelley KA, Pasinetti GM, Roberts JL, Mobbs CV 2003 Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin deficient obese mice. Diabetes 52:2675-2683
23. Savontaus E, Breen TL, Kim A, Yang LM, Chua ST, Wardlaw SL 2004 Metabolic effects of transgenic melanocyte stimulating hormone overexpression in lean and obese mice. Endocrinology 145:3881-3891
24. Kao PC, Taylor RL, Service FJ 1994 Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma. J Clin Endocrinol Metab 78:1048-1051
25. Lacombe M-J, Mercure C, Dikeakos JD, Reudelhuber TL 2005 Modulation of secretory granule-targeting efficiency by cis and trans compounding of sorting signals. J Biol Chem 280:4803-4807
26. White A, Smith H, Hoadley M, Dobson SH, Radcliffe JG 1987 Clinical evaluation of a two-site immunoradiometric assay for adrenocorticotrophin in unextracted human plasma using monoclonal antibodies. Clin Endocrinol (Oxf) 26:41-52
27. Crosby SR, Stewart MF, Radcliffe JG, White A 1988 Direct measurement of precursors of adrenocorticotrophin in human plasma by two-site immunoradiometric assay. J Clin Endocrinol Metab 67:1272-1277
28. Gibson S, Crosby SR, White A 1993 Discrimination between β-endorphin and β-lipotropin in human plasma using two-site immunoradiometric assays. Clin Endocrinol (Oxf) 39:445-453
29. Gibson S, Crosby SR, Stewart MF, Jennings AM, McCall E, White A 1994 Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays. J Clin Endocrinol Metab 78:835-841
30. Warhurst A, Oliver RL, Pritchard LE, White A, The proprotein convertase PC1/3 regulates steady-state ACTH biosynthesis in AtT20 cells. Program of the 88th Annual Meeting of The Endocrine Society, Boston, MA, 2006 (Abstract P1-56)
31. Rousseau K, Kauser S, Pritchard LE, Warhurst A, Oliver RL, Slominski A, Wei ET, Thody AJ, Tobin DJ, White A 2007 Proopiomelanocortin (POMC), the ACTH/ melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J 21:1844-1856
32. Tsigos C, Crosby SR, Gibson S, Young RJ, White A 1993 Proopiomelanocortin is the predominant adrenocorticotropin-related peptide in human cerebrospinal fluid. J Clin Endocrinol Metab 76:620-624
33. Pritchard LE, Oliver RL, McLoughlin JD, Birtles S, Lawrence CB, Turnbull AV, White A 2003 Pro-opiomelanocortin (POMC) derived peptides in rat cerebrospinal fluid and hypothalamic extracts: evidence that secretion is regulated with respect to energy balance. Endocrinology 144:760-766
34. Perello M, Stuart RC, Nillni EA 2007 Differential effects of fasting and leptin on proopiomelanocortin peptides in the arcuate nucleus and in the nucleus of the solitary tract. Am J Physiol Endocrinol Metab 292:E1348-E1357
35. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T 1998 The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95:15043-15048
36. Ollmann MM, Wilson BD, Yang Y-K, Kerns JA, Chen Y, Gantz I, Barsh GS 1997 Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135-138
37. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL 1997 Hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice. Genes Dev 11:593-602
38. 83-132 and melanocortin receptors cannot be influenced by syndecan 3. Endocrinology 147:1621-1631
39. Reizes O, Clegg DJ, Strader AD, Benoit SC 2006 A role for syndecan-3 in the melanocortin regulation of energy balance. Peptides 27:274-280
40. Goto K, Inui A, Takimoto Y, Yuzuriha H, Asakawa A, Kawamura Y, Tsuji H, Takahara Y, Takeyama C, Katsuura G, Kasuga M 2003 Acute intracerebroventricular administration of either carboxyl-terminal or aminoterminal fragments of agouti-related peptide produces a long-term decrease in energy expenditure in rats. Int J Mol Med 12:379-383
41. Pritchard LE, White A 2005 Agouti-related protein: More than a melanocortin-4 receptor antagonist? Peptides 26:1759-1770
42. Lu X-Y, Shieh K-R, Kabbaj M, Barsh GB, Akil H, Watson SJ 2002 Diurnal rhythm of agouti-related protein and its relation to corticosterone and food intake. Endocrinology 143:3905-3915
43. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson M-L, Sanders L, Montague CT, Hutton JC, O'Rahilly S 1997 Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 16:303-306
44. Jackson RS, Creemers JWM, Farooqi IS, Raffin-Sanson M-L, Varro A, Dockray GJ, Holst JJ, Brubaker PL, Corvol P, Polonsky KS, Ostrega D, Becker KL, Bertagna X, Hutton JC, White A, Dattani MT, Hussain K, Middleton SJ, Nicole TM, Milla PJ, Lindley KL, O'Rahilly S 2003 Small intestine dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 112:1550-1560
45. Lloyd DJ, Bohan S, Gekakis N 2006 Obesity, hyperphagia and increased metabolic efficiency in PC1 mutant mice. Hum Mol Genet 15:1884-1893
46. Zhu X, Zhou A, Dey A, Norrbom C, Carroll R, Zhang C, Laurent V, Lindberg I, Ugleholdt R, Holst JJ, Steiner DF 2002 Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA 99:10293-10298
47. Zhu X, Orci L, Carroll R, Norrbom C, Ravazzola M, Steiner DF 2002 Severe block in processing of proinsulin to insulin accompanied by elevation of des-64-65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proc Natl Acad Sci USA 99:10299-10304
48. Ugleholdt R, Zhu X, Deacon CF, Orskov C, Steiner DF, Holst JJ 2004 Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1. Endocrinology 145:1349-1355
49. Nilaweera KN, Ellis C, Barrett P, Mercer JG, Morgan PL 2003 Precursor protein convertase 1 gene expression in the mouse hypothalamus: differential regulation by ob gene mutation, energy deficit and administration of leptin, and coexpression with prepro-orexin. Neuroscience 119:713-720
50. fat mice. J Biol Chem 276:1466-1473
51. Jing E, Nillni EA, Sanchez VC, Stuart RC, Good DJ 2004 Deletion of the Nhlh2 transcription factor decreases the levels of the anorexigenic peptides a melanocyte stimulating hormone and thyrotropin-releasing hormone and implicates prohormone convertases I and II in obesity. Endocrinology 145:1503-1513
52. Li QL, Jansen E, Friedman TC 1999 Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines. Mol Cell Endocrinol 158:143-152
53. Helwig M, Khorooshi RM, Tups A, Barrett P, Archer ZA, Exner C, Rozman J, Braulke LJ, Mercer JG, Klingenspor M 2006 PC1/3 and PC2 gene expression and post-translational endoproteolytic pro-opiomelanocortin processing is regulated by photoperiod in the seasonal Siberian hamster (Phodopus sungorus). J Neuroendocrinol 18:413-425
54. Furuta M, Yano H, Zhou A, Rouille Y, Holst JJ, Carroll R, Ravazzola M, Orci L, Furuta H, Steiner DF 1997 Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci USA 94:6646-6651
55. Dumermuth E, Moore H-P 1998 Analysis of constitutive and constitutive-like secretion in semi-intact pituitary cells. Methods 16:188-197
56. Cool DR, Fenger M, Snell CR, Loh YP 1995 Identification of the sorting signal motif within proopiomelanocortin for the regulated secretory pathway. J Biol Chem 270:8723-8729
57. Cool DR, Normant E, Shen F, Chen H, Pannell L, Zhang Y, Loh YP 1997 Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpefat mice. Cell 88:73-83
58. Chevrier D, Fournier H, Nault C, Zollinger M, Crine P, Boileau G 1993 Targeting of proopiomelanocortin to the regulated secretory pathway may involve cooperation between different protein domains. Mol Cell Endocrinol 94:213-221
59. Mulcahy LR, Vaslet CA, Nillni EA 2005 Prohormone-convertase 1 processing enhances post-Golgi sorting of prothyrotropin-releasing hormone-derived peptides. J Biol Chem 280:39818-39826
60. Garcia AL, Han S-K, Janssen WG, Khaing ZZ, Ito T, Glucksman MJ, Benson DL, Salton SRJ 2005Aprohormone convertase cleavage site within a predicted α-helix mediates sorting of the neuronal and endocrine polypeptide VGF into the regulated secretory pathway. J Biol Chem 280:41595-41608
61. Marzban L, Trigo-Gonzalez G, Verchere CB 2005 Processing of pro-islet amyloid polypeptide in the constitutive and regulated secretory pathways of β cells. Mol Endocrinol 19:2154-2163
62. Zhou A, Mains RE 1994 Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. J Biol Chem 269:17440-17447
63. Zhou Y, Rovere C, Kitabgi P, Lindberg I 1995 Mutational analysis of PC1 (SPC3) in PC12 cells. 66-kDa PC1 is fully functional. J Biol Chem 270:24702-24706
64. Zhou Y, Lindberg I 1994 Enzymatic properties of carboxyl-terminally truncated prohormone convertase 1 (PC1/SP3) and evidence for autocatalytic conversion. J Biol Chem 269:18408-18413
65. Salvas A, Bejannet S, Reudelhuber TL, Chretien M, Seidah NG 2005 Evidence for proprotein convertase activity in the endoplasmic reticulum/early golgi. FEBS Lett 579:5621-5625
66. Jutras I, Seidah NG, Reudelhuber TL, Brechler V 1997 Two activation states of the prohormone convertase PC1 in the secretory pathway. J Biol Chem 272:15184-15188
67. Milgram SL, Mains RE 1994 Differential effects of temperature blockade on the proteolytic processing of three secretory granule-associated proteins. J Cell Sci 107:737-745
68. Paquet L, Zhou A, Chang EY, Mains RE 1996 Peptide biosynthetic processing: distinguishing prohormone convertases PC1 and PC2. Mol Cell Endocrinol 120:161-168
69. Cameron A, Fortenberry Y, Lindberg I 2000 The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1. FEBS Lett 473:135-138
70. Landry M, Vila-Porcile E, Hokfelt T, Calas A 2003 Differential routing of coexisting neuropeptides in vasopressin neurons. Eur J Neurosci 17:579-589
71. Fumagalli G, Zanini A 1985 In cow anterior pituitary, growth hormone and prolactin can be packed into separate granules of the same cell. J Cell Biol 100:2019-2024
72. Fisher JM, Sossin W, Newcomb R, Scheller RH 1988 Multiple neuropeptides derived from a common precursor are differentially packaged and transported. Cell 54:813-822
73. Biebermann H, Castaneda TR, van Landeghem F, von Deimling A, Escher F, Brabant G, Hebebrand J, Hinney A, Tshop MH, Gruters A, Krude H 2006 A role for β-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab 3:141-146
74. Challis BG, Pritchard LE, Creemers JWM, Delplanque J, Keogh JM, Luan J, Wareham NJ, Yeo GSH, Bhattacharyya S, Froguel P, White A, Farooqi IS, O'Rahilly SO 2002 A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early onset obesity through a novel molecular mechanism. Hum Mol Genet 17:1997-2004
75. Lee YS, Challis BG, Thompson DA, Yeo GSH, Keogh JM, Madonna ME, Wraight V, Sims M, Vatin V, Meyre D, Shield J, Burren J, Ibraham Z, Cheetham T, Swift P, Blackwood A, Hung C-CC, Wareham NJ, Froguel P, Millhauser GL, O'Rahilly S, Farooqi IS 2006 A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab 3:135-140
76. Appleyard SM, Hayward M, Young JI, Butler AA, Cone RD, Rubinstein M, Low MJ 2003 A role for endogenous opioid β-endorphin in energy homeostasis. Endocrinology 144:1753-1760
77. Glass MJ, Billington CJ, Levine AS 1999 Opioids and food intake: distributed functional neural pathways? Neuropeptides 33:360-368
78. Brakch N, Allemandou F, Cavadas C, Grouzmann E, Brunner HR 2002 Dibasic cleavage site is required for sorting to the regulated secretory pathway for both pro- and neuropeptide Y. J Neurochem 81:1166-1175
79. Brechler V, Chu WN, Baxter JD, Thibault G, Reudelhuber TL 1996 A protease processing site is essential for prorenin sorting to the regulated secretory pathway. J Biol Chem 271:20636-20640
80. Bundgaard JR, Birkedal H, Rehfeld JF 2004 Progastrin is directed to the regulated secretory pathway by synergistically acting basic and acidic motifs. J Biol Chem 279:5488-5493
81. Feliciangeli S, Kitabgi P, Bidard J-N 2001 The role of dibasic residues in prohormone sorting to the regulated secretory pathway. J Biol Chem 276:6140-6150